Cannabis ein sicherer mid-bigcap- Hafen?
The FV Pharma state-of-the-art facility (the “Facility”), hosts an existing 620,000 square feet of building space and is famously known as the former KRAFT® food manufacturing facility. The Facility is ideally situated only one hour east of Toronto in Cobourg, Ontario, off of the 401 highway and has access by car or rail to Ottawa and Montreal.
Pursuant to the Agreement, the Company will receive a 49.9% stream of all cannabis (or cannabis-derived products including any immature cannabis plants and any cannabis trim) produced at the Facility, under partnership with Cannabis Wheaton, in perpetuity (the “Cannabis Wheaton Allocation”). The Company estimates that the Cannabis Wheaton Allocation will result in approximately 200,000,000 grams of cannabis for the Company’s benefit per annum upon completion of all phases of the Facility Development.
In exchange for the Cannabis Wheaton Allocation, using its unique expertise and experience the Company’s management team will assist FV Pharma with all aspects of the design, development, financing, build-out and operations of the Facility as well as the marketing, branding and distribution of all cannabis and cannabis-derived products generated by the Facility.
In addition, the Company will also participate in the governance of FV Pharma by having one Company nominee appointed to the board of directors of FV Pharma.
Chuck Rifici, Chairman and Chief Executive Officer of Cannabis Wheaton commented, "As a cornerstone asset in the Cannabis Wheaton portfolio, we are excited to start this journey with the FV Pharma team to build-out a truly world class facility. As I previously mentioned, this project is special to us as it will not only create additional and much needed supply for the medical and recreational Canadian cannabis markets but also has the potential to create hundreds of jobs for the City of Cobourg."
Thomas Fairfull, President and CEO of FV Pharma said, “We couldn’t have asked for a better joint venture partner for the development of our world class facility and the execution of our business plan that we expect will create hundreds of quality skilled jobs for the City of Cobourg. We are excited at the opportunity to build and operate something special with Cannabis Wheaton and to set the gold standard for cannabis cultivation and for cannabis-derived consumer products.”
ON BEHALF OF THE BOARD
"Chuck Rifici" Chairman & CEO
das Teil hoch volatil ist.Wenn ich mir den ETF auf Mariuana anschau der hat in drei Monaten
125% zugelegt.Man darf aber nicht vergessen in USA dürfen z.Z. nur 5 Staaten das Zeug
anbaun u.ab 21Jahren konsumieren.Inden andern ists streng verboten
also in 8 Staaten.Die WKN des Fonds : A2DTQB guck mal
Cannabis Wheaton to help Honest with pot drink facility
2018-03-15 10:29 ET - News Release
Mr. Chuck Rifici reports
CANNABIS WHEATON INCOME CORP. ANNOUNCES STRATEGIC ALLIANCE AGREEMENT WITH PROVINCE BRANDS OF CANADA
Cannabis Wheaton Income Corp. has entered into a strategic alliance agreement with Ontario-based research and development firm Honest Inc. (Province), whereby the company will assist Province with the establishment and licensing of a cannabis facility focused on the research, development and commercialization of cannabis-based beverages.
Pursuant to the agreement, and subject to applicable laws, the company will assist Province in obtaining the federal licensing necessary for Province to engage in the research, development and commercialization of cannabis-based beverages through its Wheaton licensing program by providing Province with the resources and expertise necessary to achieve the licence.
In connection with the strategic alliance, the company will receive 2,068,284 preferred shares in the capital of Province, representing a 10-per-cent equity ownership interest in Province on a fully diluted basis, and to further the strategic alliance between the two companies, Cannabis Wheaton will issue 303,030 common shares to Province. The agreement shall last for at least three years and shall automatically renew for one-year periods unless otherwise mutually terminated by the company and Province. The company and Province have also agreed to explore and collaborate on further commercial opportunities including supply and off-take arrangements, cannabis genetics development and refinement, co-branding opportunities, white-label opportunities, IP development and licensing as well as international distribution opportunities.
Dooma Wendschuh, co-founder and chief executive officer of Province, commented: "Today marks a giant leap forward for Province in our mission to create a safer and healthier alternative to alcohol. We are thrilled with the opportunity to partner with Chuck, Hugo and the rest of the Cannabis Wheaton team on this adventure, as Province aims to become the first company to develop a premium line of beverages brewed exclusively from the cannabis plant, as well as other premium cannabis-powered, alcohol-free beers and spirits. Here's to a partnership which we hope will create tremendous value for Province and Cannabis Wheaton's shareholders and create lots of phenomenal cannabis-based products for everyone else."
Hugo Alves, president of Cannabis Wheaton, stated: "We are very excited about this collaboration with Province. We believe that our regulatory and industry expertise, coupled with Province's accomplished team, will be a winning combination for both companies as we work to develop unique consumer products and formulations which we believe will eventually play a huge role in the cannabis industry and ultimately be disruptive to the alcohol industry. We look forward to partnering with Province and helping them build an industry-leading global brand in the cannabis beverage vertical."
The agreement remains subject to certain conditions precedent, including receipt of applicable regulatory approvals and the approval of the TSX Venture Exchange.
About Cannabis Wheaton Income Corp.
Cannabis Wheaton is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. The company's mandate is to facilitate growth for its partners by providing them with financial support and sharing its collective industry experience. Cannabis Wheaton's partners all have different visions, voices and brand values, and all share a common goal--to build a world-class industry based on ethics, diversity, quality and innovation.
© 2018 Canjex Publishing Ltd. All rights reserved.
ORIGINAL: Cannabis Wheaton Income Corp. Provides Update on the Initial Development of FV Pharma Inc. Facility
2018-03-16 07:00 ET - News Release
VANCOUVER, British Columbia, March 16, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) ("CannabisWheaton" or the "Company") is pleased to provide an update on the initial development of its project with streaming partner FV Pharma Inc. ("FV Pharma"). The FV Pharma facility (the “Facility”) is located in Cobourg, Ontario and hosts an existing 620,000 square feet of building space. Since signing a definitive agreement (the "Agreement") the Company and FV Pharma have been eagerly advancing the design, construction budget and timeline for the development of the Facility.
Pursuant to the Agreement, the Company will develop and finance all aspects of FV Pharma’s Facility in mutually agreed phases of construction and arrange for the build-out, commissioning and operations. The Company will receive a 49.9% stream of all cannabis (or cannabis-derived products including any immature cannabis plants and any cannabis trim) produced at the Facility, under partnership with Cannabis Wheaton, in perpetuity.
The Company has determined that the first phase development of the Facility will be a retrofit of the existing building to construct approximately 100,000 square feet of cultivation and ancillary space (“Phase I”). The Company and FV Pharma are actively working to finalize the funding and timing associated with the development of Phase I which is estimated to cost approximately $35,000,000. It is anticipated that Phase I will be fully completed and licensed within 18 months.
Based on the design, construction budget and timeline of Phase I, the Company and FV Pharma will continue to develop the phased-in construction approach for the existing Facility. The second phase and third phase developments of the existing Facility will be a further retrofit of the existing building and will be an aggregate of approximately 200,000 additional square feet of cultivation and ancillary space ("Phases II and III"). The Company expects to construct Phases II and III concurrently with Phase I and anticipates that construction will be completed on an expedited basis subject to the Company’s and FV Pharma’s determination of construction efficiency, Facility operation, regulatory approvals, market demand and availability of financing. The concurrent construction of Phase I and Phases II and III will allow the Company to significantly reduce the costs of construction for Phases II and III by, among other things, efficiently managing the design, labour and construction material costs for such phases.
ON BEHALF OF THE BOARD
"Chuck Rifici" Chairman & CEO
About Cannabis Wheaton (TSX.V: CBW)
Cannabis Wheaton is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. Our mandate is to facilitate growth for our partners by providing them with financial support and sharing our collective industry experience. Our partners all have different visions, voices and brand values, and all share a common goal—to build a world-class industry based on ethics, diversity, quality and innovation.
Investor Relations:
For more information about investing in Cannabis Wheaton, please visit: http://www.wheatonincome.com or contact our Investor Relations Team:
Email: IR@wheatonincome.com
Phone: 1-833-695-2414
Stay Connected:
Follow up on Twitter @WheatonIncome.
Media Enquiries (only):
For media enquiries or to set up an interview please contact:
Sarah Bain, VP External Affairs
Email: sarah@cannabiswheaton.com
Phone: 613.230.5869
About FV Pharma.
FV Pharma’s management mission is to make the former Kraft plant in Cobourg, Ontario the largest hydroponic cannabis indoor facility in the world. FV Pharma intends to target all aspects of the cannabis industry including cultivation, processing, manufacturing, R&D, medical products, concentrates, beverages and edibles when and only when it is legal to do so. The facility is only a one hour drive east of Toronto on the 401 highway. FV Pharma has an ACMPR License from Health Canada. FV Pharma is currently a private company.
Stay Connected:
For further information about FV Pharma Inc. and our management team, please visit: http://www.fvpharma.com or contact Thomas Fairfull ((905) 686-7079 or Thomas.fairfull@fvpharma.com) or Anthony Durkacz ((416) 720-4360 or anthony@firstrepubliccapital.com).
Notice Regarding Forward Looking Information:
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: expectations of future growing capacity at the Facility and the projected costs associated with each expansion phase of the Facility; the completion of the planned build-out and expansion phases; the funding requirements for each expansion phase; the projected revenue achievable by the Facility; and the proposed licensing of the Facility and the expected timing to obtain all necessary licenses required for the proposed operation of the Facility. By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company or the Facility to be materially different from those expressed or implied by such information and statements.
A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: sufficient funding can be obtained to complete each phased expansion of the Facility in the manner proposed or at all; the Company and FV Pharma can satisfy the conditions associated with the Facility’s cultivation license; a sales authorization can be obtained for the license and the related timing considerations; the Company and FV Pharma can obtain all necessary governmental and regulatory permits and approvals for the Facility, including in relation to the construction of each proposed expansion phase, and whether such permits and approvals can be obtained in a timely manner; FV Pharma complies with its obligations under the Agreement; the Facility can be operated as intended; current and future management will abide by the investment objectives and investment strategies of the Company; the Company will supplement its board of directors and management, or otherwise engage consultants and advisors, having knowledge of the industries in which the Company invests; streaming partners will be able to generate cash flow; general economic, financial market, regulatory and political conditions in which the Company operates will remain the same; the Company will be able to compete in the industry; the Company will be able to manage anticipated and unanticipated costs; the Company will be able to enter into additional streaming agreements; the Company will be able to maintain internal controls over financial reporting and disclosure, controls and procedures; streaming partners will be able to meet the requirements necessary to obtain and / or maintain their status as licensed entities; and streaming partners will be able to successfully complete initial construction and / or expansion construction of their respective facilities pursuant to the terms and conditions of their respective streaming agreements. Additional risk factors are disclosed in the revised annual information form of the Company for the financial year ended December 31, 2016 dated May 23, 2017.
New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party industry sources, the accuracy of which has not been verified by the Company. The purpose of forward-looking information is to provide the reader with a description of management's expectations, and such forward-looking information may not be appropriate for any other purpose. Readers should not place undue reliance on forward-looking information contained in this release.
The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
:)
https://www.stockwatch.com/Quote/Detail.aspx?symbol=CBW®ion=C
20. März, 07:39
Cobourg Legal Marijuana Plant to Hire 200 People in Next 12 Months➸ https://www.northumberlandnews.com/news-story/...e-in-next-12-months/
Wheaton Income Home➸ https://wheatonincome.com/
AltaCorp and ATB: Energy, Agriculture and Diversified Institutional Investor Conference➸ January 9 - 11, 2018➸ https://lnkd.in/djbuvpG
CBW at a Glance➸ https://lnkd.in/dRcBRuB
Cobourg marijuana plant to hire 200 people in next 12 months | NorthumberlandNews.com
NP/CP say Manitoba keen to hide pot smokers
2018-03-21 07:01 ET - In the News
See In the News (C-WEED) Canopy Growth Corp
The National Post reports in its Wednesday edition that even after the federal government legalizes recreational marijuana later this year, Manitobans are not likely to have many places where they will be allowed to use it. A Canadian Press dispatch to the Post says that the Progressive Conservative government introduced a bill Tuesday that would forbid people from smoking or vaping cannabis in almost all public areas. Streets, school grounds, parks, beaches, restaurant patios, and sports and entertainment venues would all be off limits. Most indoor public places would also be cannabis-free, with exceptions such as designated rooms in palliative care facilities. Health Minister Kelvin Goertzen said that the province wants to ban cannabis in some areas where people can smoke and drink out of caution and because the government does not want to "normalize" its use. Penalties would be similar to existing ones for smoking tobacco in a forbidden place -- starting at $100 to $500 for a first offence and climbing for subsequent infractions. The bill calls for people to be allowed to light up in their homes and on their property, but tenants might have few options if their landlords forbid cannabis smoking.
© 2018 Canjex Publishing Ltd. All rights reserved.
Morgen wirds wohl bergauf gehen
Cannabis Wheaton Income Corp
Symbol C : CBW
Shares Issued 424,109,403
Close 2018-03-26 C$ 1.64
Recent Sedar Documents
View Original Document
Cannabis Wheaton grants options to buy 1.11M shares
2018-03-27 08:17 ET - News Release
Mr. Chuck Rifici reports
CANNABIS WHEATON INCOME CORP. ANNOUNCES OPTION GRANT
Cannabis Wheaton Income Corp. has granted 1.11 million options to purchase common shares of the company to certain directors and officers pursuant to the company's stock option plan. All options will vest in equal portions over the following three years. All of the options are exercisable at a price of $1.80 per common share. The options have a term of 10 years and are subject in all respects to the terms of the plan and the requirements of the TSX Venture Exchange.
About Cannabis Wheaton Income Corp.
Cannabis Wheaton is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. Its mandate is to facilitate growth for the company's partners by providing them with financial support and sharing its collective industry experience. The company's partners all have different visions, voices and brand values, and all share a common goal -- to build a world-class industry based on ethics, diversity, quality and innovation.
© 2018 Canjex Publishing Ltd. All rights reserved.
Schade aber der Sprung war auch stark
Moderation
Zeitpunkt: 04.04.18 17:54
Aktion: Löschung des Beitrages
Kommentar: Urheberrecht: Text ohne Einverständnis des Urhebers veröffentlicht
Zeitpunkt: 04.04.18 17:54
Aktion: Löschung des Beitrages
Kommentar: Urheberrecht: Text ohne Einverständnis des Urhebers veröffentlicht
Zur NAFTA zählt auch Kanada,seine Einstellung zu Cannabis ist ja bekannt.
Der für 2019 geplante Start der Cannabis-Ernte für medizinische Zwecke in Deutschland ist kaum noch zu schaffen.
Das Oberlandesgericht (OLG) Düsseldorf stoppte das Vergabeverfahren um den Anbau und die Lieferung von zunächst 6,6 Tonnen Cannabis.
SMITHS FALLS, ON, April 5, 2018 /CNW/ - Canopy Rivers Corporation ("Canopy Rivers"), Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) and LiveWell Foods Canada Inc. ("LiveWell"), today announced that the companies have executed a strategic agreement to accelerate the development and commercialization of Livewell's two large scale cannabis projects located in Ottawa, ON and Pontiac, QC, which collectively represent over 1,500,000 sq. ft. of future cannabis production and processing infrastructure.
"This new partnership represents further validation that Canopy is the platform of choice in the cannabis sector," said Bruce Linton, Chairman and CEO of Canopy Growth. "Canopy has an unmatched ability to collaborate with partners given our breadth of operational knowledge, technology, investment capital, and cultivation expertise."
"Rivers continues to look for synergistic and mutually beneficial opportunities to support emerging industry players with strategic advisory services and financial support," said Sean McNulty, Co-founder, Canopy Rivers. "We will work collaboratively with Canopy Growth to accelerate LiveWell's speed to market and deploy the resulting offtake throughout Canopy's industry leading distribution platforms. With their Ottawa project located less than an hour from Canopy Growth's Smith Falls headquarters, and 5 minutes from the airport, Livewell, once developed, represents a complimentary supplement to our portfolio of production and distribution partners."
Canopy's experienced team will provide Livewell with high-quality genetics for initial cultivation, access to trained personnel for guidance/support, assistance with standard operating procedures for compliance, and other strategic and financial support as needed to assist LiveWell in getting its facilities licensed and fully operational. Once licensed, LiveWell will also benefit from launching its brand(s) via Canopy Growth's extensive distribution network including Tweedmainstreet.com, the largest registered patient network in the industry, and Canopy Growth's extensive recreational retail channels.
"Partnering with Canopy Growth and Canopy Rivers, the leaders in the cannabis industry, provides LiveWell with the best in class partners required to execute on our ambitious growth plans in an efficient and expedited manner," said LiveWell's CEO Seann Poli. "Having access to their operational excellence, unique technology, global distribution infrastructure, and an abundance of other industry insights, we can significantly de-risk the execution and operation at both facilities. These significant executional efficiencies will drastically reduce our time to market and improve the quality of product we deliver."
As part of the agreement, subject to the completion of certain milestones, Canopy Growth and Canopy Rivers, will each be issued equity in LiveWell. LiveWell has also received an initial purchase agreement from Canopy, for cannabis production at the Ottawa Project. In addition, LiveWell has the option to draw on up to $20,000,000 of debt financing from Canopy Rivers (subject to the completion of certain milestones) to support Livewell's continued growth initiatives.
LiveWell Foods Canada Overview
LiveWell is a vertically integrated cannabis company with a full seed-to-sale solution including two large scale cannabis greenhouse projects in development totaling over 1,500,000 square feet. In addition to dried bud and oil, the company's technology enables it to produce high value extracts and isolates for use in precise dosed medicinal formulations, and future recreational and edibles markets. LiveWell also distributes retail and bulk hemp products under the O-Hemp brand.
Artiva Project Overview (Ottawa, Ontario)
In late 2017 Artiva completed the acquisition of Sole Produce and now owns 100 acres of prime agricultural land located five minutes from the Ottawa International Airport and ten minutes from downtown Ottawa. The farm has been in operation since 1993 and currently produces eggplant, zucchini, and mini cucumber under 740,000 square feet of greenhouse, serving local and national grocers. The Phase I retrofit of 108,000 square feet of greenhouse and 36,000 square feet of indoor support is well underway and construction is scheduled for completion in Q2 of this year. LiveWell is the first company in Ottawa to be permitted to grow cannabis within the city limits. The ACMPR application for this site has been submitted; and subject to Health Canada and other standard regulatory approvals, the Company anticipates being ready to begin in summer of 2018. Once Phase I is completed and licensed the plan is to immediately retrofit the balance of the facility brining the total planned project to 540,000 sq. ft. all under one roof.
Pontiac Project Overview (Litchfield, Quebec)
The 500 acre Pontiac site offers excellent conditions for sustainable development, innovation, investment, and partnership support. The site is ideally situated on the Ottawa River, one hour North-West of Gatineau, Quebec. It has an abundant water supply and power at some of the most competitive rates in North America. The site will host a Global Innovation Centre complete with a Cannabis and Hemp Research & Processing facility allowing for the development of precisely dosed consumable products for the medicinal, pharmaceutical, nutraceutical, and recreational consumer markets. The total planned project footprint is one million square feet of hybrid greenhouse and construction of the first 100,000 square feet has already begun.
About LiveWell
LiveWell Foods Canada Inc. (Ottawa, Canada) is dedicated to the highest quality standards in delivering cannabis and hemp products. Together with its strategic partner, Canopy Growth Corporation (TSX: WEED) and Canopy Rivers Corporation, LiveWell is retrofitting an existing 540,000 square foot greenhouse facility in Ottawa, Ontario. LiveWell is also constructing a state of the art Global Innovation Centre complete with a Cannabis and Hemp Research & Processing facility and 1 million square foot grow, in Litchfield, Quebec. Upon completion, the combined will measure 1,540,000 square feet of greenhouse capacity, all built to an unparalleled level of quality assurance, procedures, and testing. The company has established partnerships with leading sector names, with interests and operations abroad. LiveWell also distributes retail and bulk hemp products under the O-Hemp brand and plans to distribute cannabis edibles and infused products.
For more information visit www.livewellfoods.ca
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.
Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates seven cannabis production sites with over 1 million square feet of production capacity, including over 500,000 square feet of GMP-certified production space. The Company has operations in seven countries across four continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth.
For more information visit www.canopygrowth.com
Notice Regarding Forward Looking Statements
This news release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canopy Growth Corporation, its subsidiaries, or its affiliates to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Examples of such statements include future operational and production capacity, the impact of enhanced infrastructure and production capabilities, and forecasted available product selection. The forward-looking statements included in this news release are made as of the date of this news release and Canopy Growth Corporation does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Canopy Growth Corporation
For further information: Jordan Sinclair, Director of Communications, Jordan@tweed.com, 613-769-4196; Investor Relations, Tyler Burns, Tyler.burns@canopygrowth.com, 855-558-9333 ex 122; Director: Bruce Linton, tmx@tweed.com